.png)
The initiative seeks to establish a nexus between educational institutions and industries, with the overarching goal of imparting comprehensive insights into career prospects beyond the confines of academia.
Designed to guide undergraduate and postgraudate students in developing industry-focused resume, refining personal statements, and enhancing interview preparation skills, all of which are tailored to align with industry standards. The series will feature interactive sessions, allowing students to engage in discussions, pose questions and receive constructive feedback for continuous improvement.
Between 3-4 speakers will be invited to share their diverse career journeys, ranging from holding positions in an industry to the development of bio-tech start-ups. Their insights will provide valuable perspectives on navigating and succeeding in various facets of the industry ecosystem.
.png)
.png)
Sign up for our monthly newsletter of upcoming events, recently published insights and SEC updates.
Kadence Bio (formerly Kanna Health) is a clinical-stage drug development company pioneering new treatments for sexual health. Their lead asset, KH-001, is being developed as the first FDA-approved treatment for premature ejaculation. The company recently completed a Phase I clinical trial and is planning to initiate Phase II trials next year.
Laura Castillo De Franca
October 14, 2024
CardiaTec is at the forefront of drug development for cardiovascular diseases. Through sequencing and AI, they are generating the largest multiomics dataset surrounding human hearts to uncover novel therapeutics.
Lucy Ahern
November 20, 2024
Cultivated or cultured meat is an exciting technology that provides an alternative to traditional farmed, animal meat. It has various advantages in environmental impact, animal welfare, and more. Meatly is a start-up producing cultivated, lab-grown meat and what sets them apart is that they specialise in producing pet food.
Sandeep Mangrati
November 20, 2024
Sep 18
To mourn the end of summer, we're bringing together both our BioFounder Club and BioCapital Network communities for an Investor-Founder Mixer.
London, UK
Apr 25
From design of synthetic peptides to carbon-sequestering concrete, to sustainable fashion biomaterials are booming in today's market. Our mixer dinners offer unique opportunities for start-ups and investors alike.
May 14
Now firmly established in laboratories around the world, gene editing and it's reaching impact throughout Biotech depends on fresh, innovative companies to keep this momentum and create novel therapeutic avenues. Our mixer dinners offer unique opportunities for start-ups and investors alike.
London
Jul 3
We're changing the status quo of low female representation in Venture Capital through our in-house community of women investors in the life sciences across the UK and beyond.
London